بررسی عوامل تأثیرگذار بر بازار مصرف داروهای تخصصی در ایران
الموضوعات :
علیرضا رضوانی چمن زمین
1
,
ناصر فقهی فرهمند
2
,
موسی رضوانی چمن زمین
3
,
یعقوب علوی متین
4
1 - دانشجوی دکترای مدیریت بازرگانی، گروه مدیریت، واحد تبریز، دانشگاه آزاد اسلامی، تبریز، ایران
2 - گروه مدیریت، واحد تبریز، دانشگاه آزاد اسلامی، تبریز، ایران
3 - گروه مدیریت، واحد آستارا، دانشگاه آزاد اسلامی، آستارا، ایران
4 - گروه مدیریت، واحد تبریز، دانشگاه آزاد اسلامی، تبریز، ایران
الکلمات المفتاحية: الگوی مصرف, بازار مصرف دارو, دارو, داروهای تخصصی,
ملخص المقالة :
مقدمه: بازار محصولات دارویی از بزرگترین و پردرآمدترین بازارهای دنیاست که ارقام بالایی هر ساله در آن رد و بدل می‌شود. بازاری که هر تصمیم‌گیری نادرست درباره آن به سرعت بازار سیاه را رونق می‌بخشد و دلالان دارو را قوی‌تر می‌کند. پژوهش حاضر با هدف بررسی عوامل تأثیرگذار بر بازار مصرف داروهای تخصصی در ایران صورت پذیرفته است.روش پژوهش: نتایج پژوهش پیش به روش کمی مورد بررسی قرار گرفته است. روش مورد استفاده در این پژوهش مبتنی بر مطالعات بنیادی است. پژوهش حاضر بر اساس روش گردآوری داده‌ها یک پژوهش پیمایشی - مقطعی است. در این مطالعه از روش نمونه‌گیری هدفمند برای انتخاب خبرگان و روش تصادفی ساده به تعداد 385 مورد استفاده قرار گرفته است.یافته‌ها: نتایج نشان داد که دو عامل تعدیلگری کاهش سود انحصاری بر روابط بین فرآوری و سهولت مصرف بر پیش‌بینی بازار مصرف دارو با ضریب 414/4 با سطح معناداری 0/0001 که از حد تعیین آلفا = 0/05 کوچکتر است، به عنوان مهم‌ترین عامل و تعدیلگری کاهش سود انحصاری بر روابط بین دسترسی به مطب و پزشک بر پیش بینی بازار مصرف دارو با ضریب 2/355 و سطح معناداری 0/0001 به دو عامل مهم در تاثیر گذاری بر پیش‌بینی بازار مصرف داروهای تخصصی در ایران قابل شناسایی هستند.نتیجه‌گیری: در نهایت می‌توان گفت با توجه به تاثیر زیاد ویژگی‌های دارو و خصوصیات بیمار در انتخاب دارو بهتر است شرکت‌های بازاریابی وقت و انرژی خود را روی بازاریابی داروهایی با پروفایل دارویی مطلوب تر(از نظر پزشکان) بالا قرار دهند.
1- Omidinejad M, Alijanzadeh F, Abdizdan Gh. Comparison of the effect of cold dialysis solution with normal on blood pressure and dialysis duration tolerance in patients undergoing hemodialysis treatment in Malair city in 2017. National conference on promoting the health of the individual, family and society; 2018.
2 Bahrami H, Azizi M, Badiazadeh A, Shirsewar H. Institutional factors influencing the internationalization of pharmaceutical technology companies. Health management; 2019: 19-30.
3- Begum M, Rashidbaghan A. Practical guide to diagnosis and treatment of thalassemia. Courier Basil; 2013.
4- Pourreza A and Khabeiri R. Health and Aging Economics, Iran Geriatrics Journal; 2015: 80-87.
5- Perivi M, Ahmadi Marzaleh M. Resilient drug supply chain in disaster response phase. 9th International Congress on Health in Accidents and Disasters; 2018.
6- A comprehensive analysis of the pharmaceutical industry, prepared in the investment consulting of Sahem Ashna Brokerage; 2015.
7- Tagvi A and Moqtader Kargan M. marketing of pharmaceutical products, World Conference on Psychology and Educational Sciences, Law and Social Sciences at the beginning of the third millennium, Shiraz; 2015.
8- Diestre L, Rajagopalan N & Dutta S. Constraints in acquiring and utilizing directors' experience: An empirical study of new‐market entry in the pharmaceutical industry. Strategic Management Journal, 2015; 36(3): 339-359.
9- Shah S, Musonda T & Menon S. To examine the impacts of Iota on pharmaceutical supply chain management in Zambia. International Journal of Internet of Things and Web Services, 2019; 6: 14-18.
10- Zahiri B, Jula P & Tavakkoli-Moghaddam R. Design of a pharmaceutical supply chain network under uncertainty considering perishability and substitutability of products. Information Sciences, 2018; 423: 257-283.
11- Bertoldi A D, Wagner A K, Emmerick C M, et al. The Brazilian private pharmaceutical market after the first ten years of the generics law. Journal of pharmaceutical policy and practice, 2019; 12(1): 18.
12- Button P. Population Aging, Age Discrimination, and Age Discrimination Protections at the 50th Anniversary of the Age Discrimination in Employment Act. In Current and Emerging Trends in Aging and Work; 2020: 163-188. Springer, Cham.
13- Costa T, Borges-Tiago T & Tiago F. Pharmaceutical Communication over Social Media Channels: 24/7 Management Challenges. In Digital Communication Management; 2018: 77-96.
14- Dathaev U M, Shopabayeva A R & Еrganova R B. Trends of the global pharmaceutical market development. News of Pharmacy, 2020; 1(99): 58-63.
15- Dégardin K, Roggo Y & Margot P. Understanding and fighting the medicine counterfeit market. Journal of pharmaceutical and biomedical analysis, 2014; 87, 167-175.
16- Emilsson V, Gudnason V & Jennings L L. Predicting health and life span with the deep plasma proteome. Nature Medicine, 2019; 25(12): 1815-1816.
17- Lawrence X Y, Amidon G, Khan M A. et al. Understanding pharmaceutical quality by design. The AAPS journal, 2014; 16(4): 771-783.
18- Gottlieb G. The logic of choice: An investigation of the concepts of rule and rationality. Rutledge; 2019.
19- Grepperud S & Andreas P P. Positioning and negotiations: The case of pharmaceutical pricing. European Journal of Political Economy; 2020: 101-853.
20- Lopes M R, Costigliola A, Pinto R M, et al. Novel governance model for planning in pharmaceutical quality control laboratories. IFAC-Papers Online, 2018; 51(11): 484-489.
21- Hulme S, Hughes C E & Nielsen S. The price and mark up of pharmaceutical drugs supplied on the black market. International Journal of Drug Policy, 2020; 76: 102626.
22- Köhler S, Friedli T & Basu P. Operational Excellence in Pharmaceutical Quality Control Labs: Driver of an Effective Quality System. Journal of Pharmaceutical Innovation; 2019: 1-17.
23- Salter, B., & Salter, C. The politics of ageing: health consumers, markets and hegemonic challenge. Sociology of health & illness, 2018; 40(6): 1069-1086.
24- Mayor S. Pfizer will not apply for a license for sildenafil for women. Bmj, 2004; 328(7439): 542.
25- Pestun I V, Mnushko Z M & Ievtushenko O M. Marketing research of the Pharmaceutical market in Ukraine: Peculiarities, Trends, Problems, Tendencies. Research Journal of Pharmacy and Technology, 2019; 12(4): 2049-2054.
_||_1- Omidinejad M, Alijanzadeh F, Abdizdan Gh. Comparison of the effect of cold dialysis solution with normal on blood pressure and dialysis duration tolerance in patients undergoing hemodialysis treatment in Malair city in 2017. National conference on promoting the health of the individual, family and society; 2018.
2 Bahrami H, Azizi M, Badiazadeh A, Shirsewar H. Institutional factors influencing the internationalization of pharmaceutical technology companies. Health management; 2019: 19-30.
3- Begum M, Rashidbaghan A. Practical guide to diagnosis and treatment of thalassemia. Courier Basil; 2013.
4- Pourreza A and Khabeiri R. Health and Aging Economics, Iran Geriatrics Journal; 2015: 80-87.
5- Perivi M, Ahmadi Marzaleh M. Resilient drug supply chain in disaster response phase. 9th International Congress on Health in Accidents and Disasters; 2018.
6- A comprehensive analysis of the pharmaceutical industry, prepared in the investment consulting of Sahem Ashna Brokerage; 2015.
7- Tagvi A and Moqtader Kargan M. marketing of pharmaceutical products, World Conference on Psychology and Educational Sciences, Law and Social Sciences at the beginning of the third millennium, Shiraz; 2015.
8- Diestre L, Rajagopalan N & Dutta S. Constraints in acquiring and utilizing directors' experience: An empirical study of new‐market entry in the pharmaceutical industry. Strategic Management Journal, 2015; 36(3): 339-359.
9- Shah S, Musonda T & Menon S. To examine the impacts of Iota on pharmaceutical supply chain management in Zambia. International Journal of Internet of Things and Web Services, 2019; 6: 14-18.
10- Zahiri B, Jula P & Tavakkoli-Moghaddam R. Design of a pharmaceutical supply chain network under uncertainty considering perishability and substitutability of products. Information Sciences, 2018; 423: 257-283.
11- Bertoldi A D, Wagner A K, Emmerick C M, et al. The Brazilian private pharmaceutical market after the first ten years of the generics law. Journal of pharmaceutical policy and practice, 2019; 12(1): 18.
12- Button P. Population Aging, Age Discrimination, and Age Discrimination Protections at the 50th Anniversary of the Age Discrimination in Employment Act. In Current and Emerging Trends in Aging and Work; 2020: 163-188. Springer, Cham.
13- Costa T, Borges-Tiago T & Tiago F. Pharmaceutical Communication over Social Media Channels: 24/7 Management Challenges. In Digital Communication Management; 2018: 77-96.
14- Dathaev U M, Shopabayeva A R & Еrganova R B. Trends of the global pharmaceutical market development. News of Pharmacy, 2020; 1(99): 58-63.
15- Dégardin K, Roggo Y & Margot P. Understanding and fighting the medicine counterfeit market. Journal of pharmaceutical and biomedical analysis, 2014; 87, 167-175.
16- Emilsson V, Gudnason V & Jennings L L. Predicting health and life span with the deep plasma proteome. Nature Medicine, 2019; 25(12): 1815-1816.
17- Lawrence X Y, Amidon G, Khan M A. et al. Understanding pharmaceutical quality by design. The AAPS journal, 2014; 16(4): 771-783.
18- Gottlieb G. The logic of choice: An investigation of the concepts of rule and rationality. Rutledge; 2019.
19- Grepperud S & Andreas P P. Positioning and negotiations: The case of pharmaceutical pricing. European Journal of Political Economy; 2020: 101-853.
20- Lopes M R, Costigliola A, Pinto R M, et al. Novel governance model for planning in pharmaceutical quality control laboratories. IFAC-Papers Online, 2018; 51(11): 484-489.
21- Hulme S, Hughes C E & Nielsen S. The price and mark up of pharmaceutical drugs supplied on the black market. International Journal of Drug Policy, 2020; 76: 102626.
22- Köhler S, Friedli T & Basu P. Operational Excellence in Pharmaceutical Quality Control Labs: Driver of an Effective Quality System. Journal of Pharmaceutical Innovation; 2019: 1-17.
23- Salter, B., & Salter, C. The politics of ageing: health consumers, markets and hegemonic challenge. Sociology of health & illness, 2018; 40(6): 1069-1086.
24- Mayor S. Pfizer will not apply for a license for sildenafil for women. Bmj, 2004; 328(7439): 542.
25- Pestun I V, Mnushko Z M & Ievtushenko O M. Marketing research of the Pharmaceutical market in Ukraine: Peculiarities, Trends, Problems, Tendencies. Research Journal of Pharmacy and Technology, 2019; 12(4): 2049-2054.
